JACQUELINE ARMSTRONG: Open Payments
NPI 1619504867 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,092 in 49 payments from 13 companies in 2025. Trend: 2023 $1,453 · 2024 $1,728 · 2025 $1,092
Food & beverage: $1,092
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $223 |
| Tris Pharma Inc | 9 | $172 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $136 |
| Lundbeck LLC | 5 | $127 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| ABBVIE INC. | 4 | $78 |
| Vanda Pharmaceuticals Inc. | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 2 | $54 |
| Alkermes, Inc. | 2 | $45 |
| Indivior Inc. | 1 | $40 |
Products named: Auvelity, Dyanavel XR, REXULTI, TRINTELLIX, VRAYLAR, COBENFY, LYBALVI, HETLIOZ.
Industry payments across DE — which companies pay providers there.
